ABSTRACT
INTRODUCTION: Mucormycosis is the third among deep fungal opportunistic infections after candidiasis and aspergillosis. It is a rare fungal infection in children, but often fatal, which occurs in immunocompromised patients. It is caused by fungi belonging to the order of mucorales. It causes extensive damage and decaying soft parts. The authors report the case of a sinonasal mucormycosis with fatal outcome in a child suffering from hemophagocytic syndrome. REPORT: PL, aged 23 months, resulting from non-consanguineous parents, hospitalized for management of hemophagocytic syndrome lasting for 2 months suspected on clinical and biological data. This diagnosis was confirmed on histology. The etiological diagnosis was negative. A broad-spectrum antibiotics and corticosteroids was introduced. A month later, the patient developed necrotic lesions in the nose and facing the right maxillary sinus. CT scan of facial mass objectived ethmoïdomaxillary bilateral sinusitis. The mycological examination of a nasal swab showed the presence of non-compartmentalized hyphae, culture on Sabouraud chloramphenicol medium without actidione at 37°C isolated Absidia corymbifera. Treatment with amphotericin B was initiated but not tolerated. The negative trend was rapidly leading to death. CONCLUSION: Rhinocerebral mucormycosis is a rare fungal infection in children, we must know how to keep it in mind. The mycological examination and/or histology of a local levy allows rapid diagnosis. Treatment should be initiated urgently to improve the prognosis.
ABSTRACT
Guillain-Barré is a rare, autoimmune disease of the peripheral nervous system. It can affect all ages beginning in the intrauterine or neonatal period. Clinical forms are diverse and include acute motor axonal neuropathy (AMAN). We report on a pediatric case of AMAN. A 2.5-year-old child presented with acute flaccid paralysis and preserved reflexes. Etiologic investigations argued in favor of Guillain-Barré syndrome in its AMAN form. Treatment based on IV immunoglobulins resulted in a total decline of paralysis and motor recovery. The AMAN form of Guillain-Barré syndrome should be considered as a potential diagnosis in all cases of acute flaccid paralysis with preserved reflexes.
Subject(s)
Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/drug therapy , Immunoglobulins, Intravenous/administration & dosage , Immunologic Factors/administration & dosage , Child, Preschool , Female , Guillain-Barre Syndrome/immunology , Humans , Paralysis/drug therapy , Treatment OutcomeABSTRACT
SETTING: The utility of interferon-gamma release assays (IGRAs), such as the QuantiFERON-TB Gold In-Tube (QFT-GIT) test, in diagnosing active tuberculosis (TB) in children is unclear and depends on the epidemiological setting. OBJECTIVE: To evaluate the performance of QFT-GIT for TB diagnosis in children living in Morocco, an intermediate TB incidence country with high bacille Calmette-Gurin vaccination coverage. DESIGN: We prospectively recruited 109 Moroccan children hospitalised for clinically suspected TB, all of whom were tested using QFT-GIT. RESULTS: For 81 of the 109 children, the final diagnosis was TB. The remaining 28 children did not have TB. QFT-GIT had a sensitivity of 66% (95%CI 5277) for the diagnosis of TB, and a specificity of 100% (95%CI 88100). The tuberculin skin test (TST) had lower sensitivity, at 46% (95%CI 3360), and its concordance with QFT-GIT was limited (69%). Combining QFT-GIT and TST results increased sensitivity to 83% (95%CI 6992). CONCLUSION: In epidemiological settings such as those found in Morocco, QFT-GIT is more sensitive than the TST for active TB diagnosis in children. Combining the TST and QFT-GIT would be useful for the diagnosis of active TB in children, in combination with clinical, radiological and laboratory data.